Drug Profile
Diacamph
Latest Information Update: 14 Nov 2003
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class Antihyperglycaemics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Diabetes mellitus
Most Recent Events
- 14 Nov 2003 Discontinued - Preclinical for Diabetes mellitus in Ukraine (unspecified route)
- 10 Jul 1998 No-Development-Reported for Diabetes mellitus in Ukraine (Unknown route)
- 26 Apr 1995 Preclinical development for Diabetes mellitus in Ukraine (Unknown route)